Natalizumab for the treatment of relapsing multiple sclerosis

Natalizumab for the treatment of relapsing multiple sclerosis

Richard A Rudick1, Michael A Panzara21Cleveland Clinic Foundation, Cleveland, OH, USA; 2Biogen Idec, Inc., Cambridge, MA, USAAbstract: Natalizumab is an α4-integrin antagonist approved as monotherapy for patients with relapsing multiple sclerosis (MS), based on demonstrated efficacy in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Richard A Rudick, Michael A Panzara
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/4b8f45d87cdf40a88c04b2ca437e248d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares